Navigation Links
Vitamins C and E linked to metabolic syndrome in low-income Ecuadorians
Date:1/4/2011

BOSTON (January 4, 2010) With life expectancy increasing in Latin America, age-related disease has become a pressing public health concern. Results of an epidemiological study conducted by researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HNRCA) at Tufts University and the Corporacion Ecuatoriana de Biotecnologia showed that the metabolic syndrome, a condition that increases a person's risk of developing cardiovascular disease and type 2 diabetes, was prevalent in a low-income urban community in Ecuador and that a poor diet low in micronutrients appeared to contribute.

The study enrolled 225 women and 127 men age 65 and older, living in three low-income neighborhoods on the outskirts of Quito, the capital of Ecuador. The authors examined the relationship between the metabolic syndrome and micronutrients such as folate, zinc and vitamins C, B12 and E. The participants reported their food intake in biweekly interviews and provided blood samples.

Using the International Diabetes Foundation (IDF) definition, the authors determined that 40 % of the population had the metabolic syndrome, with a disproportionate number of women affected: 81 % compared to 19% of the men, which the authors attribute to more of the women being overweight. According to the IDF, the metabolic syndrome is present in centrally obese men and women, as defined by hip and waist measurements, with at least two of the four following metabolic risk factors: raised triglycerides, reduced high-density lipoprotein (HDL) cholesterol, raised blood pressure, and raised fasting plasma glucose (blood sugar).

"In this population of low-income Ecuadorians, we observed a pattern of high carbohydrate, high sodium diets lacking in healthy fats and good sources of protein. Our blood analyses indicates a significant number of participants weren't consuming enough of a range of micronutrients," says senior author Simin Nikbin Meydani, PhD, DVM, d
'/>"/>

Contact: Andrea Grossman
617-636-3728
Tufts University, Health Sciences
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study Finds Vitamins E and C Dont Reduce Cataract Risk in Men
2. B vitamins and the aging brain examined
3. Vitamins needed to help celiacs stave off bone disease
4. Vitamins D, E Might Help Maintain Brain Health
5. Vitamins for Life Inventory Extended to Wellness Products, Higher Nature Supplements
6. More Evidence That B Vitamins Alone Wont Counter Heart Risks
7. Rich Vitamins Proves Taking Vitamins Doesn't Have to be a Pill with New alternaVites
8. Natural Health Online Retailer VitaminsForLife.co.uk Expands Inventory to Meet UK Demands
9. Publix Pharmacy Now Offers Pill Glide, an Innovative New Way for Children and Adults to Take Vitamins, Supplements and Medications
10. Announcing NutriVite, Liquid Multivitamin Shots - Welcome to the Future of Vitamins
11. Vitamins Fail to Protect Men Against Bladder Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... 2014 Psychogenic Non-epileptic Seizures (PNES), also ... disorder that can have devastating effects on those who ... seizures however, they are not produced by electrical anomalies ... It is estimated that the numbers of persons suffering ... sclerosis. , Dr. Lorna Myers, Director of ...
(Date:8/31/2014)... MedixSafe has become very popular in ... narcotics lockers . Electronic Security Specialists ... distribution worldwide. “We have now shipped multiple orders to ... Sales Manager , MedixSafe is a division of Electronic ... cabling company with over 30 years in the security ...
(Date:8/31/2014)... BambooIndustry.com, one of the most popular suppliers of bamboo products, ... bamboo veneers . Additionally, it has deiced offer autumn discounts( ... products. The promotion will last from today until September 16. ... quality veneers are hot in the global market. “We are ... All these items are made according to our latest study ...
(Date:8/31/2014)... With years of hard work, Delta has now ... machines. Recently, the company has updated its wheel loader ... loaders. All these items are guaranteed to be great. Additionally, ... , It is true that all items in Delta’s ... machine specialists. The firm is making full efforts to help ...
(Date:8/31/2014)... Asked to offer tips for consumers ... "absorption," Dr. Priya Khan, Director of Research & ... "Bioavailability" and "absorption" are possibly the most misused, ... second perhaps only to the confusion over food-based ... related, are not the same. Bioavailability refers to ...
Breaking Medicine News(10 mins):Health News:The Northeast Regional Epilepsy Group (NEREG) Offers First Conference on Psychogenic Non-epileptic Seizures (PNES) on September 20, 2014 in New Jersey 2Health News:Memphis-based Electronic Security Specialists Now Offers MedixSafe Narcotics Cabinets Internationally 2Health News:Memphis-based Electronic Security Specialists Now Offers MedixSafe Narcotics Cabinets Internationally 3Health News:High Quality Bamboo Veneers from Bambooindustry.com Receive International Attention 2Health News:Delta Updates Its Wheel Loader Assortment With A Lot Of Cheap Used Cat 966 Loaders 2Health News:Bioavailability Vs Absorption - NutriGold Publishes Tips to Help Consumers Make Informed Decisions for Their Health 2Health News:Bioavailability Vs Absorption - NutriGold Publishes Tips to Help Consumers Make Informed Decisions for Their Health 3Health News:Bioavailability Vs Absorption - NutriGold Publishes Tips to Help Consumers Make Informed Decisions for Their Health 4
... NEW BRUNSWICK, N.J., May 13 Johnson & Johnson ... Deutsche Bank 34th Annual Health Care Conference on Tuesday, ... Sheri McCoy, Worldwide Chairman, Pharmaceuticals Group for Johnson ... scheduled at 10:50 a.m. (Eastern Time).This broadcast will be ...
... 13 Accumetrics, Inc. announces that it has enrolled ... ( G auging R esponsiveness with A ... hrombosis A nd S afety). The trial ... clinicians with actionable information for patients who are poor ...
... Shengtai,Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai" or ... pharmaceutical grade,glucose products in China, today announced that ... ended March 31, 2009 after the close of ... Management will conduct a conference call,on Friday, May ...
... (Nasdaq: ESRX ) announced that it will present ... May 19, 2009 at 10:10 a.m. EDT at the InterContinental ... the Internet and can be accessed on the investor relations ... RealPlayer or Windows Media Player is needed to listen ...
... Winner Medical Group Inc.,(OTC Bulletin Board: WMDG) ("Winner Medical", or ... ended March 31,2009. The Company,s results are detailed in its ... Commission. , , Second Quarter 2009 Highlights, ... 15.31% over the second quarter of, ...
... expression and activity of Cystathionase is reduced in ... and impaired generation of hydrogen sulphide, two factors ... resistance. , In the present study the analysis ... presence of an inverted repeat sequence. Administration of ...
Cached Medicine News:Health News:Accumetrics, Inc. Announces 1000th Patient Enrolled in GRAVITAS Trial 2Health News:Shengtai Pharmaceutical Schedules 2009 Third Quarter Financial Results and Conference Call 2Health News:Shengtai Pharmaceutical Schedules 2009 Third Quarter Financial Results and Conference Call 3Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 2Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 3Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 4Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 5Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 6Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 7Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 8Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 9Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 10Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 11Health News:Farnesoid X receptor regulates cystathionase 2
(Date:8/29/2014)... Utah , Aug. 29, 2014  BC Technical, ... has acquired Polaris Medical Imaging, a leader in sales, ... This strategic acquisition allows BC Technical to continue to ... specifically within MR and CT modalities. ... service," said Mark Alvarez , president and CEO ...
(Date:8/29/2014)... -- Research and Markets has announced the ... & Pipeline Insight 2014" report to their offering. ... and eradicate the prevalence of cancer have achieved limited ... low specificity, safety and large number of side effects, ... solution. It has been discovered that peptides can be ...
(Date:8/29/2014)... August 29, 2014 According ... Market by Extraction type (SFE, Cold Pressed, Organic ... Care, Pharmaceutical, Food Supplements, Fragrance, & Others) - Global ... defines and segments the Amaranth Seed Oil Market ... size in terms of value. The Amaranth Seed ...
Breaking Medicine Technology:BC Technical Acquires Polaris Medical Imaging 2Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4
... 4 Shire plc ... biopharmaceutical company, today announced that the US Food and ... information for its once-daily Attention Deficit Hyperactivity Disorder (ADHD) ... CII, to include supplemental data demonstrating significant improvement in ...
... , May 4 Kaiser Permanente, committed to improving the ... require suppliers to provide environmental data for $1 billion worth ... other facilities. , , , ... Scorecard is the first of its kind in health care. It will ...
Cached Medicine Technology:FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 2FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 3FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 4FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 5FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 6FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 7FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 8Kaiser Permanente Launches Sustainability Scorecard for Medical Products 2Kaiser Permanente Launches Sustainability Scorecard for Medical Products 3
... IMMULITE 2000 assays are ... the IMMULITE 2000, a ... immunoassay analyzer. IMMULITE 2000 ... centralization, and a rapidly ...
... sulfate (DHEA-S) is the sulfate ester of ... enzymatic conversion of DHEA in adrenal and ... steroid secreted by the adrenal cortex, and ... biosynthesis. DHEA possesses relatively weak androgenic activity, ...
... sulfate ester of DHEA, derived from sulfated ... in adrenal and extradrenal tissues. DHEA is ... adrenal cortex, and is a precursor for ... weak androgenic activity, which for unsulfated DHEA ...
Inquire...
Medicine Products: